FENNEC TO PRESENT AT PIONEERS 2017 JOSEPH GUNNAR CONFERENCE ON MAY 2, 2017 IN NEW YORK CITY Read more about FENNEC TO PRESENT AT PIONEERS 2017 JOSEPH GUNNAR CONFERENCE ON MAY 2, 2017 IN NEW YORK CITY
FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES FIRST QUARTER 2017 RESULTS Read more about FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES FIRST QUARTER 2017 RESULTS
FENNEC ANNOUNCES LAUNCH OF EUROPEAN NAMED PATIENT PROGRAMME FOR SODIUM THIOSULFATE FOR PEDIATRIC PATIENTS WITH STANDARD RISK HEPATOBLASTOMA Read more about FENNEC ANNOUNCES LAUNCH OF EUROPEAN NAMED PATIENT PROGRAMME FOR SODIUM THIOSULFATE FOR PEDIATRIC PATIENTS WITH STANDARD RISK HEPATOBLASTOMA
FENNEC ANNOUNCES $7.6 MILLION PRIVATE PLACEMENT OF COMMON SHARES LED BY VENBIO SELECT ADVISOR Read more about FENNEC ANNOUNCES $7.6 MILLION PRIVATE PLACEMENT OF COMMON SHARES LED BY VENBIO SELECT ADVISOR
FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING Read more about FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING
FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES SECOND QUARTER 2017 RESULTS Read more about FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES SECOND QUARTER 2017 RESULTS
FENNEC PHARMACEUTICALS ANNOUNCES LISTING ON THE NASDAQ CAPITAL MARKET Read more about FENNEC PHARMACEUTICALS ANNOUNCES LISTING ON THE NASDAQ CAPITAL MARKET
FENNEC ANNOUNCES PRELIMINARY RESULTS OF SIOPEL 6 STUDY ON PEDMARK™ (SODIUM THIOSULFATE) TO BE PRESENTED AT THE 49TH CONGRESS OF THE INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY (SIOP) 2017 MEETING Read more about FENNEC ANNOUNCES PRELIMINARY RESULTS OF SIOPEL 6 STUDY ON PEDMARK™ (SODIUM THIOSULFATE) TO BE PRESENTED AT THE 49TH CONGRESS OF THE INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY (SIOP) 2017 MEETING
FENNEC TO PRESENT AT THE CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE ON SEPTEMBER 27, 2017 IN NEW YORK CITY Read more about FENNEC TO PRESENT AT THE CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE ON SEPTEMBER 27, 2017 IN NEW YORK CITY
